Africa (WHO region) vs Mali: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Africa (WHO region)
27.0%
in 2025
Mali
68.0%
in 2025
Africa (WHO region) rank
5th
Mali rank
6th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Africa (WHO region)
- Mali
How they compare
Mali currently reports 68.0% against 27.0% in Africa (WHO region), a difference of 41.0%.
That makes Mali's figure about 2.5 times Africa (WHO region)'s.
Across all 10 years both countries report, Mali has been ahead every year.
Africa (WHO region) ranks 5th and Mali ranks 6th of 7 groups.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.8% | 44.8% | 36.0% | Mali |
| 2020s | 25.7% | 66.5% | 40.8% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Africa (WHO region) or Mali?
- Mali, at 68.0% against 27.0% in Africa (WHO region) as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Africa (WHO region) and Mali?
- 41.0%, with Mali ahead.
- How many years of comparable data are there for Africa (WHO region) and Mali?
- 10 years are reported by both, from 2016 to 2025.
- How do Africa (WHO region) and Mali rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Africa (WHO region) ranks 5th and Mali ranks 6th of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.